Drug Profile
Research programme: toll-like receptor agonists - Kindeva Drug Delivery
Alternative Names: 3M 011; 854 A; S 34240Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator 3M Drug Delivery Systems
- Developer Kindeva Drug Delivery
- Class Skin disorder therapies
- Mechanism of Action Toll-like receptor 7 agonists; Toll-like receptor 8 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Skin disorders
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Skin-disorders in USA (Topical)
- 03 Aug 2016 Toll-like receptor agonists is available for licensing as of 03 Aug 2016. www.3m.com
- 03 Aug 2016 S 34240 has patent protection (3M Drug Delivery Systems website, August 2016)